Fig. 6From: Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysisValidation of the differential expression of six hub genes in various clinical stages. ANOVA was used to assess the statistical significance of the differences. Results showed that 3 of 6 hub genes were significantly differentiated in various clinical stagesBack to article page